Efficacy and safety of DA-6034(AJU-S56/GLH8NDE) in patients with dry eye disease: A multicenter, randomized, double-blinded, placebo-controlled phase 2 study

被引：0
|
作者：
Kim, Eunjung [1 ]
Park, Jun [1 ]
Chung, Tae [2 ]
机构：
[1] GL PharmTech, R&D, Seongnam, Gyeonggi Do, South Korea
[2] Samsung Med Ctr, Ophthalmol, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3980
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): The Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2a IRIS-RA Study
    Taylor, Peter C.
    Schett, Georg
    Ibrahim, Fowzia
    Zhou, Bei
    Leu, Jocelyn H.
    Liva, Sophia G.
    Wang, Qingmin
    Cella, Ricardo Rojo
    Karyekar, Chetan S.
    Fei, Kaiyin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1682 - 1684
  • [22] Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
    Rosas, I.
    Solomon, J.
    Donoff, S.
    Woodhead, F.
    Raghu, G.
    Hilary, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Efficacy And Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage(CHAIN):Protocol for a Randomized Placebo-controlled Double-blinded Multicenter Trial
    Zhao, Yang
    Cui, Wanzhen
    Xie, Tingting
    Zhao, Kai
    Li, Yunke
    Wan, Yingfeng
    Wang, Xia
    Li, Qiang
    Chen, Xiaoying
    Liu, Zhenchuan
    Zhao, Haining
    Gong, Baoying
    Wang, Ruihua
    Wu, Manli
    Wang, Dou
    Zheng, Yanwen
    Chen, Yanjia
    Chen, Yue
    Guo, Qihua
    Gan, Changlian
    Che, Fengyuan
    Song, Lili
    Anderson, Craig S.
    Guo, Jianwen
    CEREBROVASCULAR DISEASES, 2023, 52 : 41 - 41
  • [24] Efficacy and safety of Chinese Herbal medicine in patients with Acute INtracerebral hemorrhage (CHAIN): protocol for a randomized placebo-controlled double-blinded multicenter trial
    Zhao, Yang
    Cui, Wanzhen
    Xie, Tingting
    Zhao, Kai
    Li, Yunke
    Wan, Yingfeng
    Wang, Xia
    Li, Qiang
    Chen, Xiaoying
    Liu, Zhenchuan
    Zhao, Haining
    Gong, Baoying
    Wang, Ruihua
    Wu, Manli
    Wang, Dou
    Zheng, Yanwen
    Chen, Yanjia
    Chen, Yue
    Guo, Qihua
    Gan, Changlian
    Che, Fengyuan
    Song, Lili
    Anderson, Craig S.
    Guo, Jianwen
    CEREBROVASCULAR DISEASES, 2024, 53 (04)
  • [25] A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis
    Zhang, Chunlei
    Yan, Kexiang
    Diao, Qingchun
    Guo, Qing
    Jin, Hongzhong
    Yang, Sen
    Chen, Xiang
    Lei, Tiechi
    Wu, Jianhua
    Yu, Hong
    Zheng, Min
    Gao, Xinghua
    Sinclair, Rodney
    Zhu, Yi
    Xu, Qian
    Xu, Jinhua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (01) : 95 - 102
  • [26] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
  • [27] Pharmacodynamic Effects of Nipocalimab on Disease Biomarkers in Patients with Moderate-to-Severe Active Sjogren's Disease: Results from a Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2 Study
    Sivils, Kathy
    Leonardo, Steven
    Li, He
    Ma, Keying
    Loza, Matthew J.
    Hubbard, Jonathan J.
    Campbell, Kim
    Gao, Sheng
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4616 - 4618
  • [28] A 12-WEEK, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2B STUDY OF SAFETY, TOLERABILITY AND EFFICACY OF AR882 IN GOUT PATIENTS
    Wei, J. C. C.
    Fleischmann, R. M.
    Morris, S.
    Polvent, E.
    Shen, Z.
    Roche, A. Clouser
    Hingorani, V.
    Yan, S.
    Yeh, L. T.
    Keenan, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 192 - 192
  • [29] Safety and efficacy of ketorolac in improving the prognosis of acute type A aortic dissection patients: a protocol of a randomized, double-blinded, and placebo-controlled study
    Lv, Zhikang
    Pan, Tuo
    Zhang, Haitao
    Wang, Yapeng
    Matniyaz, Yusanjian
    Tang, Yuxian
    Lu, Lichong
    Wang, Dongjin
    TRIALS, 2024, 25 (01)
  • [30] Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study
    Hyun, M. Y.
    Son, I. P.
    Lee, Y.
    Choi, H. G.
    Park, K. Y.
    Li, K.
    Kim, B. J.
    Seo, S. J.
    Kim, M. N.
    Hong, C. K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (02) : 278 - 282
12345